Abstract
Cyclic AMP is an ubiquitous molecule that serves as an important second messenger for multiple signaling pathways. At least nine membrane-bound mammalian isoforms of adenylyl cyclase have been identified, and each isoform has a distinct pattern of tissue distribution as well as interaction with regulatory proteins within local cytosolic environment. Adenylyl cyclase is coupled to G-protein receptors and serves to convert ATP to cAMP. Although many of the upstream G-protein receptors and cAMP regulators such as phosphodiesterase have been utilized as targets of pharmacotherapy, the attempt of pharmacologic regulation of adenylyl cyclase itself has not been successful. Recent studies have characterized the distinct physiologic effect of each adenylyl cyclase isoform within different organ systems, suggesting the potential therapeutic utility of isoform-specific regulators of adenylyl cyclase. In the current review, we aim to discuss the effects of genetic regulation for each adenylyl cyclase isoform as well as the development of isoformspecific adenylyl cyclase regulators including their therapeutic potential.
Keywords: cAMP, adenylyl cyclase, P-site inhibitor, forskolin, phosphodiesterase, protein kinase A, G-protein coupled receptor, Epac, adenosine triphosphate, memory loss
Current Enzyme Inhibition
Title:Recent Advance in Isoform-Specific Regulation of Adenylyl Cyclase
Volume: 8 Issue: 2
Author(s): David Wei-Kang Ho, Masanari Umemura, Claudio Bravo and Kousaku Iwatsubo
Affiliation:
Keywords: cAMP, adenylyl cyclase, P-site inhibitor, forskolin, phosphodiesterase, protein kinase A, G-protein coupled receptor, Epac, adenosine triphosphate, memory loss
Abstract: Cyclic AMP is an ubiquitous molecule that serves as an important second messenger for multiple signaling pathways. At least nine membrane-bound mammalian isoforms of adenylyl cyclase have been identified, and each isoform has a distinct pattern of tissue distribution as well as interaction with regulatory proteins within local cytosolic environment. Adenylyl cyclase is coupled to G-protein receptors and serves to convert ATP to cAMP. Although many of the upstream G-protein receptors and cAMP regulators such as phosphodiesterase have been utilized as targets of pharmacotherapy, the attempt of pharmacologic regulation of adenylyl cyclase itself has not been successful. Recent studies have characterized the distinct physiologic effect of each adenylyl cyclase isoform within different organ systems, suggesting the potential therapeutic utility of isoform-specific regulators of adenylyl cyclase. In the current review, we aim to discuss the effects of genetic regulation for each adenylyl cyclase isoform as well as the development of isoformspecific adenylyl cyclase regulators including their therapeutic potential.
Export Options
About this article
Cite this article as:
Wei-Kang Ho David, Umemura Masanari, Bravo Claudio and Iwatsubo Kousaku, Recent Advance in Isoform-Specific Regulation of Adenylyl Cyclase, Current Enzyme Inhibition 2012; 8 (2) . https://dx.doi.org/10.2174/157340812800793282
DOI https://dx.doi.org/10.2174/157340812800793282 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current and Future Chemotherapy for Chagas Disease
Current Medicinal Chemistry Spontaneous Coronary Artery Dissection: Does Being Unemployed Matter? Insights from the GSCAD Registry
Current Cardiology Reviews Genetics and Gene Therapy of Anderson-Fabry Disease
Current Gene Therapy Targeting the Cardiomyocyte Cell Cycle for Heart Regeneration
Current Drug Targets Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review
Current Neuropharmacology Mechanisms of the Beneficial Actions of Ischemic Preconditioning on Subcellular Remodeling in Ischemic-Reperfused Heart
Current Cardiology Reviews Recent Studies on Neural Tube Defects in Embryos of Diabetic Pregnancy: An Overview
Current Medicinal Chemistry Regulation of Angiotensin II Receptor Expression
Current Pharmaceutical Design Genetics and Vaccines in the Era of Personalized Medicine
Current Genomics The Role of Myocardial Collagen Network in Hypertensive Heart Disease
Current Hypertension Reviews Targeting Mitochondrial Oxidative Stress Through Lipoic Acid Synthase: A Novel Strategy to Manage Diabetic Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacological Approaches in the Treatment of Atrial Fibrillation
Current Medicinal Chemistry Mesenchymal Stem Cells: A Good Candidate for Restenosis Therapy?
Current Vascular Pharmacology Regulatory Approaches to Nonclinical Reproductive Toxicity Testing of Anti-Cancer Drugs
Anti-Cancer Agents in Medicinal Chemistry Use of Medication in Coronary Imaging by CT
Current Medical Imaging Current State of Development of Genome Analysis in Livestock
Current Genomics Editorial: Look for Changes in 2016
Current Molecular Medicine Genetics of Cardiomyopathies: Novel Perspectives with Next Generation Sequencing
Current Pharmaceutical Design Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances
Current Clinical Pharmacology Stem Cell Therapy for the Treatment of Acute Myocardial Infarction and Chronic Ischemic Heart Disease
Current Pharmaceutical Biotechnology